Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
THC · NYSE · Health Care Facilities
Tenet Health (THC) · oqro.io/stocks/THC · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$263.19−0.40 (−0.15%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
No open-market purchase by an insider of Tenet Health was filed in the last 90 days. The latest on record was on Oct 26, 2022.
Since 2006, Tenet Health insiders reported 90 open-market purchases and 235 sales on Forms 4 and 5, with purchases in 12 different years, most recently 2022.
In the last 90 days, 7 insiders of Tenet Health (THC) reported 13 open-market sales worth $40.8M in total on SEC Form 4. The largest seller by value was Saumya Sutaria, with $27.6M. Many insider sales follow a plan set in advance or cover taxes on stock awards; the filing says what was sold, not the reason.
Yes. Members of Congress disclosed 4 trades in Tenet Health (THC) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent is from Rep. Jonathan L. Jackson (IL01).
Tenet Health's next results are expected on Feb 9, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+41.0% (+$76.51) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $186.68 on Nov 20, 2025 to $263.19 on Nov 20, 2026 (+41.0%). Disclosed in this range: 34 insider trades, 0 pre-arranged insider sales, 4 Congress trades, and 26 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care Facilities company based in Dallas, Texas.
Last 12 months
+41.0%
Market value
$20.9B
S&P 500 +5.7% over the same dates. Prices adjusted for splits and dividends.
Short interest: 1.78M shares sold short (2.2% of shares outstanding), −3.3% vs the previous count, 2.2 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
Revenue, fiscal 2025
$21.3B
+3.1% vs the year before
Net income
Not reported
As reported in the annual filing
Shares outstanding
79.6M
As of Oct 23, 2026
In fiscal 2025 the company spent $1.39B buying back its own shares. Cash actually paid, from its cash-flow statement.
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Insider selling
Traded Nov 11 · filed 3 days laterNot reported under a pre-arranged trading plan
Since the trade −10.2% · S&P 500 −9.2% · to Nov 20
A Tenet Health director sold $293K of Tenet Health shares. The filing does not indicate a pre-arranged trading plan.
Blunt Roy (Director) plans to sell ~$293K of Tenet Health
Planned, from payTraded Sep 14, 2026 · largest single transaction ~$1.44MNot reported under a pre-arranged trading plan
Sep 14, 2026~$1.44M · 5,483 sh @ $263.04
DetailsOfficial recordSep 14, 2026~$1.06M · 4,025 sh @ $264.10
DetailsOfficial recordPrices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Written by software from the filings listed below · Oct 12, 2026
One more point, with the facts they come from, are in OQRO Pro.
Sign up freeOn the public record for Tenet Health over the 12 months to Nov 21, 2026: 33 executive contributions.
Last results
Oct 29, 2026
Within the 30 days after it, until Nov 28, 2026
Next results, expected
Feb 9, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
74%
32 of 43 insider purchases since 2015 came within 30 days after a results announcement
From Tenet Health's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Tenet Health's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Insiders of Tenet Health reported 90 open-market purchases and 235 sales since 2006; purchases in 12 different years, most recently 2022.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $62.7M33×33 trades |
| 2025 | — | $36.8M35×35 trades |
| 2024 | — | $34.5M34×34 trades |
| 2023 | — | $5.42M9×9 trades |
| 2022 | $474K1×1 trade | $27.2M8×8 trades |
| 2021 | — | $446M40×40 trades |
| 2020 | $1.29M8×8 trades | $82.4M19×19 trades |
| 2019 | $52.5M15×15 trades | $2.91M2×2 trades |
| 2016 | $291K2×2 trades | — |
| 2015 | $178M17×17 trades | $21.5M10×10 trades |
| 2014 | — | $23M22×22 trades |
| 2013 | $76.8M9×9 trades | $202M10×10 trades |
| 2012 | $32.4M4×4 trades | $6.7M7×7 trades |
| 2011 | $144K1×1 trade | — |
| 2010 | $225K2×2 trades | $84K1×1 trade |
| 2008 | $441K15×15 trades | — |
| 2007 | $999K15×15 trades | $367K4×4 trades |
| 2006 | $15K1×1 trade | $1.1K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
No Schedule 13D or 13G filing on THC over the last three years: no investor has reported crossing 5% of its stock in that time.
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
Congress
Funds and stakes
Contracts, lobbying and filings
Against the S&P 500 over the year
Company reports, price and press
Who holds it
Things to keep in mind
Since Nov 19, 2025, THC is up 35.5% and the index fund is up 4.1%: 31 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much THC moves
Beta 0.6 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).
Revenue
$5.63B
+6.5% vs the same quarter a year earlier
Free cash flow, last 12 months
$3.33B
This quarter $1.08B, a year earlier $778M
Net debt
$10.4B
Debt $13.1B, cash $2.67B, at Sep 30, 2026
Backlog
$734M
Work contracted but not yet delivered, as the company reports it
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 29, 2026.
Revenue and earnings history, 18 fiscal yearsEarnings dates and the stock's moves
Fiscal year Jan 1, 2025 to Dec 31, 2025, from the annual report filed Feb 17, 2026. Read the filing
0.0% on the year before ($16.1B)
+14% on the year before ($4.53B)
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 23,000 words.
On January 27, 2026, we entered into an agreement with CommonSpirit Health (a successor to Catholic Health Initiatives) (“CHI”) relating to Conifer Health Solutions, LLC (“Conifer”). Subject to the terms of that agreement and other related contracts, the parties have agreed to, among other things: (1) terminate the amended and restated master services agreement pursuant to which Conifer provides end-to-end revenue cycle management services to certain CHI facilities effective as of December 31, 2026; (2) CHI’s payment to us of an aggregate amount equal to $1.900 billion in annual installments over the next three years; provided that, of such amount, $540 million was satisfied on January 27, 2026 by offsetting the $540 million due to CHI from Conifer as described in the next clause; (3) the…
And 26 more headings in the filing.
Source: SEC EDGAR, Form 10-K filed Feb 17, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
Off-exchange trading: 41.6% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (32.0% on ATS, 9.6% with other brokers), close to its 26-week average of 42.6%. Weeks of Oct 5 to Oct 30, 2026.
Largest ATS: INTELLIGENT CROSS LLC (14.5%), UBS ATS (12.0%), SIGMA X2 (11.1%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.
Latest annual report filed Feb 17, 2026, compared with the one filed Feb 18, 2025. Read the filing
All 25 risk factor headings match the year before, give or take wording.
Because we provide healthcare services in a highly regulated industry, we have been and expect to continue to be party to various lawsuits, claims and regulatory investigations from time to time. For information regarding material pending legal proceedings in which we are involved, see Note 17 to our Consolidated Financial Statements, which is incorporated by reference.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 17, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.